Table I.
Clinicopathological characteristics of the 25 patients with oral squamous cell carcinoma.
| Characteristics | Value |
|---|---|
| Sex, n (%) | |
| Male | 11 (44.0) |
| Female | 14 (56.0) |
| Median age, years | 68 |
| Age, range, years | 50-90 |
| Primary site, n (%) | |
| Tongue | 8 (32.0) |
| Gingiva | 14 (56.0) |
| Oral floor | 1 (4.0) |
| Intraosseous | 1 (4.0) |
| Buccal | 1 (4.0) |
| Differentiation, n (%) | |
| Well | 22 (88.0) |
| Moderate | 1 (4.0) |
| Poor | 1 (4.0) |
| Not specified | 1 (4.0) |
| ECOG Performance status, n (%) | |
| 0 | 13 (52.0) |
| 1 | 9 (36.0) |
| 2 | 3 (12.0) |
| Initial treatment, n (%) | |
| Surgery alone | 15 (60.0) |
| Surgery + adjuvant RT | 3 (12.0) |
| Surgery + adjuvant CCRT | 7 (28.0) |
| Cetuximab regimen, n (%) | |
| Cet + RT | 15 (60.0) |
| Cet + PTX | 8 (32.0) |
| Cet + FP | 1 (4.0) |
| Cet alone | 1 (4.0) |
| Median number of treatment cycles, n | 10 |
| Number of treatment cycles, range, n | 2-70 |
RT, radiotherapy; CCRT, concurrent chemoradiotherapy; PTX, paclitaxel; FP, 5-fluorouracil + cisplatin; ECOG, Eastern Cooperative Oncology Group.